Crestline Management »

Miragen Therapeutics shares owned by Crestline Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Crestline Management from 13F filings

Historical chart of Crestline Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Crestline Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Crestline Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.5M 153k 22.75

More positions owned by Crestline Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Denali Therapeutics (DNLI)
NVIDIA Corporation (NVDA)
salesforce (CRM)
Alcoa (AA)
Broadcom (AVGO)
Coherent Corp (COHR)
Norfolk Southern (NSC)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Evergy (EVRG)
PPL Corporation (PPL)
NiSource (NI)
Adobe Systems Incorporated (ADBE)
Perrigo SHS (PRGO)
Golar Lng SHS (GLNG)

View all positions for Crestline Management

Top funds holding Miragen Therapeutics

BlackRock
BlackRock
Deep Track Capital
VR Adviser
Fairmount Funds Management
Vanguard Group
Paradigm Biocapital Advisors
Perceptive Advisors
State Street Corporation
Commodore Capital
Novo A/S
Tang Capital Management
Alliancebernstein
Maverick Capital
Driehaus Capital Management

View all funds holding Miragen Therapeutics